Latest Breaking News On - Hyderabad based bharat biotech international - Page 4 : vimarsana.com

Apr 20 2021, 4:29 PM April 20 2021, 2:30 AM April 20 2021, 4:29 PM (Bloomberg) Indian drugmaker Cadila Healthcare Ltd., which expects regulatory approval for its vaccine against Covid-19 by June, will potentially ramp up capacity to 240 million annual doses as the South Asian nation races to contain the world’s fastest-growing coronavirus outbreak. (Bloomberg) Indian drugmaker Cadila Healthcare Ltd., which expects regulatory approval for its vaccine against Covid-19 by June, will potentially ramp up capacity to 240 million annual doses as the South Asian nation races to contain the world’s fastest-growing coronavirus outbreak. Ahmedabad, Gujarat-based Cadila is expecting efficacy readings from its last stage of clinical trials in May, Sharvil Patel, the family-run firm’s managing director, said in an interview. If that data is promising, the drugmaker may double its vaccine making capabilities and is banking on a new local factory that will likely be commissio

Andhra pradeshAbhishek sharmaNarendra modiBloomberg indianCadila zycoSharvil patelCadila healthcare ltdAstrazeneca plcBharat biotech international ltdSouth asianGujarat based cadilaHyderabad based bharat biotech internationalMinister narendra modiBharat biotechஆந்திரா பிரதேஷ்அபிஷேக் ஷர்மா